Ardent Health Statistics
Total Valuation
Ardent Health has a market cap or net worth of $1.35 billion. The enterprise value is $2.96 billion.
| Market Cap | 1.35B |
| Enterprise Value | 2.96B |
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ardent Health has 143.10 million shares outstanding. The number of shares has increased by 6.56% in one year.
| Current Share Class | 143.10M |
| Shares Outstanding | 143.10M |
| Shares Change (YoY) | +6.56% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 1.64% |
| Owned by Institutions (%) | 20.75% |
| Float | 23.90M |
Valuation Ratios
The trailing PE ratio is 9.83 and the forward PE ratio is 8.43. Ardent Health's PEG ratio is 12.22.
| PE Ratio | 9.83 |
| Forward PE | 8.43 |
| PS Ratio | 0.21 |
| Forward PS | 0.20 |
| PB Ratio | 1.05 |
| P/TBV Ratio | 4.23 |
| P/FCF Ratio | 5.22 |
| P/OCF Ratio | 2.87 |
| PEG Ratio | 12.22 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.14, with an EV/FCF ratio of 11.43.
| EV / Earnings | 21.77 |
| EV / Sales | 0.47 |
| EV / EBITDA | 6.14 |
| EV / EBIT | 9.08 |
| EV / FCF | 11.43 |
Financial Position
The company has a current ratio of 1.97, with a Debt / Equity ratio of 1.38.
| Current Ratio | 1.97 |
| Quick Ratio | 1.42 |
| Debt / Equity | 1.38 |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 8.96 |
| Interest Coverage | 5.90 |
Financial Efficiency
Return on equity (ROE) is 14.35% and return on invested capital (ROIC) is 7.94%.
| Return on Equity (ROE) | 14.35% |
| Return on Assets (ROA) | 3.97% |
| Return on Invested Capital (ROIC) | 7.94% |
| Return on Capital Employed (ROCE) | 7.67% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $250,966 |
| Profits Per Employee | $5,389 |
| Employee Count | 25,200 |
| Asset Turnover | 1.23 |
| Inventory Turnover | 22.75 |
Taxes
In the past 12 months, Ardent Health has paid $56.22 million in taxes.
| Income Tax | 56.22M |
| Effective Tax Rate | 19.63% |
Stock Price Statistics
The stock price has decreased by -24.92% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -24.92% |
| 50-Day Moving Average | 9.14 |
| 200-Day Moving Average | 10.96 |
| Relative Strength Index (RSI) | 55.84 |
| Average Volume (20 Days) | 334,701 |
Short Selling Information
The latest short interest is 2.84 million, so 1.99% of the outstanding shares have been sold short.
| Short Interest | 2.84M |
| Short Previous Month | 2.66M |
| Short % of Shares Out | 1.99% |
| Short % of Float | 11.90% |
| Short Ratio (days to cover) | 7.12 |
Income Statement
In the last 12 months, Ardent Health had revenue of $6.32 billion and earned $135.81 million in profits. Earnings per share was $0.96.
| Revenue | 6.32B |
| Gross Profit | 3.67B |
| Operating Income | 325.58M |
| Pretax Income | 286.36M |
| Net Income | 135.81M |
| EBITDA | 481.29M |
| EBIT | 325.58M |
| Earnings Per Share (EPS) | $0.96 |
Balance Sheet
The company has $712.49 million in cash and $2.32 billion in debt, with a net cash position of -$1.61 billion or -$11.22 per share.
| Cash & Cash Equivalents | 712.49M |
| Total Debt | 2.32B |
| Net Cash | -1.61B |
| Net Cash Per Share | -$11.22 |
| Equity (Book Value) | 1.68B |
| Book Value Per Share | 9.01 |
| Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was $470.51 million and capital expenditures -$211.90 million, giving a free cash flow of $258.61 million.
| Operating Cash Flow | 470.51M |
| Capital Expenditures | -211.90M |
| Depreciation & Amortization | 155.70M |
| Net Borrowing | -7.42M |
| Free Cash Flow | 258.61M |
| FCF Per Share | $1.81 |
Margins
Gross margin is 57.98%, with operating and profit margins of 5.15% and 2.15%.
| Gross Margin | 57.98% |
| Operating Margin | 5.15% |
| Pretax Margin | 4.53% |
| Profit Margin | 2.15% |
| EBITDA Margin | 7.61% |
| EBIT Margin | 5.15% |
| FCF Margin | 4.09% |
Dividends & Yields
Ardent Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.56% |
| Shareholder Yield | -6.56% |
| Earnings Yield | 10.05% |
| FCF Yield | 19.14% |
Analyst Forecast
The average price target for Ardent Health is $13.20, which is 39.83% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.20 |
| Price Target Difference | 39.83% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ardent Health has an Altman Z-Score of 2.07 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.07 |
| Piotroski F-Score | 8 |